Blog Category All Categories Uncategorised Clear Clear BlogCommon eCOA Implementation Mistakes That Delay Study Startup8 October 2026By Jenn AllsbrookVice President, Customer Success, North America BlogHow to Evaluate an eCOA Vendor for Global Trials20 August 2026 BlogBYOD vs. Provisioned Devices: Why Participant Choice Should Drive Your eCOA Strategy20 August 2026 BlogThree questions with… James Thatcher5 August 2026By James ThatcherChief Commercial Officer BlogWhat is eConsent in Clinical Trials?25 June 2026 BlogWhy are eCOA studies still so challenging? And, how can we make them better?3 June 2026By Florence Mowlem, PhDChief Scientific Officer Blog18 months of FDA’s Core Patient-Reported Outcomes in Cancer Clinical Trials Guidance – have we seen its impact? 26 May 2026By Florence Mowlem, PhDChief Scientific Officer BlogHow to Approach eCOA Vendor Selection: Top 5 Considerations for Clinical Trials7 May 2026 BlogBetter Experience, Better Evidence: How Human-centered Design Changes Clinical Trials14 April 2026By Bruce HellmanChief Patient Officer & Co-FounderBen JamesChief Design Officer & Co-Founder BlogClinical Trials Are All About the Data: Why Ensuring eCOA Stakeholder Alignment Is Critical13 March 2026By Steve LyonsVice President, Data Services and Enterprise Operations BlogThe Benefits of eCOA: Why Electronic Clinical Outcome Assessments Are Becoming the Standard22 January 2026 BlogAn Introduction to Clinical Outcome Assessments (COAs)22 January 2026 {{ x.card_name }}{{ x.title }}Topics: {{ t }}, {{ x.date }} Load More There are no posts to display.